Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9434928
SERIAL NO

14360243

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to recombinant adeno-associated virus (rAAV) delivery of an alpha-sarcoglycan gene. The invention provides rAAV products and methods of using the rAAV in the treatment of limb girdle muscular dystrophies such as LGMD2D.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONWIDE CHILDREN'S HOSPITAL INC700 CHILDREN'S DRIVE COLUMBUS OH 43205

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chicoine, Louis Westerville, US 4 37
Clark, Kelly Reed Columbus, US 20 140
Mendell, Jerry R Columbus, US 27 124
Preston, Thomas J Groveport, US 9 69
Rodino-Klapac, Louise Groveport, US 33 56

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00